-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE ANNOUNCES SUCCESSFUL COMPLETION OF TREATMENT AND FOLLOW-UP FOR 18 PARTICIPANTS IN ITS ONGOING PHASE I/IIA CLINICAL TRIAL OF CMND-100 FOR ALCOHOL USE DISORDER

Reuters·03/30/2026 12:31:59

Please log in to view news